Literature DB >> 28386460

Reversal of abnormal cardiac parameters following mitral valve replacement for severe mitral stenosis in relation to pulmonary artery pressure: A retrospective study of noninvasive parameters - Early and late pattern.

Usha T Parvathy1, Rajesh Rajan1, Alexander Georgevich Faybushevich1.   

Abstract

BACKGROUND AND OBJECTIVES: Although the regression of pulmonary hypertension (PH) in mitral stenosis (MS) has been studied over varying periods postintervention, corresponding studies on the cardiac chamber alterations after surgery are very limited. We sought to determine the degree of reversal of these and the clinical status in connection with that of pulmonary artery pressures (PAPs) in the early and late postoperative periods.
METHODS: The preoperative, early, and 1-year postoperative data - functional class (FC), cardiothoracic ratio (CTR) in chest X-ray (CXR), and echocardiographically left atrium (LA), right atrium (RA), right ventricle (RV), left ventricle (LV), and pulmonary artery (PA) dimensions, PAP, tricuspid regurgitation (TR) - of 50 patients who had mitral valve replacement (MVR) for MS with PH were retrospectively analyzed for correlations with PAP (Pearson's), and their change (t-test), in relation to that in PAP. PH group-based [Group (Gp)-I PAP ≤60 mmHg, Gp-II PAP >60 mmHg] analysis highlighted the differences.
RESULTS: All parameters significantly correlated with the baseline PAP (p < 0.05), except LA (r = 0.081, p = 0.577). Postoperatively, there was significant reduction in all parameters (p < 0.001) and increase in LV (p < 0.003). The PAP regression was 39.42%; with the decrease in CTR, LA, and RA related to it, the early changes being significant (p < 0.01). The RV and PA showed lesser reduction (8.61% and 9.42%), late reduction being more conspicuous. The changes were greater and significant in Gp-II (especially PAP, RV, and PA). At 1 year, PAP normalized in only 19 (38%). Residual PH and chamber enlargement prevailed more in Gp-II.
CONCLUSIONS: This study emphasizes the importance of the baseline PAP in MS to which was proportionate the functional disability and the cardiac chamber alterations (except LA). Their postoperative improvement accompanying the PAP regression differed in degree and time frame relative to PAP. The higher pressure group showed greater regression, but greater prevalence of residual abnormalities, suggesting that the pathologic changes in them might take longer to resolve, necessitating further evaluation.

Entities:  

Keywords:  cardiac chamber alterations; functional class; mitral stenosis; mitral valve replacement; pulmonary hypertension

Year:  2016        PMID: 28386460      PMCID: PMC5370351          DOI: 10.1556/1646.8.2016.2.1

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  23 in total

1.  Efficacy of valve replacement surgery in patients with severe pulmonary hypertension.

Authors:  Umer Darr; Tabish Jabeen; Shakaib Chughtai
Journal:  J Pak Med Assoc       Date:  2011-09       Impact factor: 0.781

2.  Changes in the appearances of the chest radiograph after a repair or replacement operation on the mitral valve.

Authors:  M S Gotsman; W Beck; C N Barnard; V Schrire
Journal:  Br J Radiol       Date:  1967-10       Impact factor: 3.039

3.  Roentgen interpretation of postoperative changes (clinical and hemodynamic) in pure mitral stenosis.

Authors:  R P Seningen; J T Chen; R H Peter; J J Morris; R G Lester
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-12

4.  Factors determining normalization of pulmonary vascular resistance following successful balloon mitral valvotomy.

Authors:  H Gamra; H P Zhang; J W Allen; F Y Lou; C E Ruiz
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

5.  Fate of tricuspid regurgitation after closed valvotomy for mitral stenosis.

Authors:  M Z Shafie; N Hayat; O A Majid
Journal:  Chest       Date:  1985-12       Impact factor: 9.410

6.  Significant tricuspid regurgitation does not resolve after percutaneous balloon mitral valvotomy.

Authors:  A Sagie; E Schwammenthal; I F Palacios; M E King; M Leavitt; N Freitas; A E Weyman; R A Levine
Journal:  J Thorac Cardiovasc Surg       Date:  1994-10       Impact factor: 5.209

7.  Determinants of decrease in pulmonary hypertension following percutaneous transvenous mitral commissurotomy.

Authors:  Ahmad Noor; Tahir Saghir; Khan Shah Zaman
Journal:  J Coll Physicians Surg Pak       Date:  2009-02       Impact factor: 0.711

8.  Evaluation and comparison of early hemodynamic changes after elective mitral valve replacement in patients with severe and mild pulmonary arterial hypertension.

Authors:  Deepak K Tempe; Suruchi Hasija; Vishnu Datt; A S Tomar; Sanjula Virmani; Amit Banerjee; Bhuvan Pande
Journal:  J Cardiothorac Vasc Anesth       Date:  2009-03-19       Impact factor: 2.628

9.  Pulmonary artery hypertension in mitral stenosis: Role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance.

Authors:  Praveen Kumar Neema; Ramesh Chandra Rathod
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04

10.  Tricuspid regurgitation improvement in relation to the amount of pulmonary artery pressure reduction.

Authors:  Arezou Zoroufian; Mohammad Sahebjam; Bahareh Eslami; Masoumeh Lotfi-Tokaldani; Mahmood Sheikhfathollahi; Seyed Ebrahim Kassaian
Journal:  J Tehran Heart Cent       Date:  2010-08-31
View more
  5 in total

1.  Prevalence and survival associated with pulmonary hypertension after mitral valve replacement: National echocardiography database of Australia study.

Authors:  Nicholas Collins; Stuart Sugito; Allan Davies; Andrew Boyle; Aaron Sverdlov; John Attia; Simon Stewart; David Playford; Geoff Strange
Journal:  Pulm Circ       Date:  2022-10-01       Impact factor: 2.886

2.  Venoarterial Extracorporeal Membrane Oxygenation to Facilitate Transcutaneous Mitral Valve Replacement in Critical Mitral Stenosis.

Authors:  Rachel M Clark; Sharon Bruoha; Assi Milwidsky; Edwin Ho; Sandhya Murthy; Mei L Chau; Azeem Latib; Ulrich P Jorde
Journal:  JACC Case Rep       Date:  2022-04-06

3.  Impact of preoperative pulmonary arterial hypertension on early and late outcomes in patients undergoing valve surgery for rheumatic heart disease.

Authors:  Deepak Prakash Borde; Balaji Asegaonkar; Sujit Khade; Manish Puranik; Antony George; Shreedhar Joshi
Journal:  Indian J Anaesth       Date:  2018-12

4.  Left Ventricular Dimension after Mitral Valve Surgery in Rheumatic Mitral Stenosis: The Impact of Myocardial Fibrosis.

Authors:  Teuku Muhammad Haykal Putra; Renan Sukmawan; Dwita Rian Desandri; Celly A Atmadikoesoemah; Elen Elen; Manoefris Kasim
Journal:  J Tehran Heart Cent       Date:  2020-07

5.  MitraClip® as bridging strategy for heart transplantation in Chagas cardiomyopathy: a case report.

Authors:  Juan Felipe Vasquez-Rodríguez; Héctor Manuel Medina; Jaime Ramón Cabrales; Adriana Gisella Torres
Journal:  Eur Heart J Case Rep       Date:  2020-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.